Campbell Newman Asset Management Inc Abbott Laboratories Transaction History

Campbell Newman Asset Management Inc

$1.11 Billion
Q1 2025

A detailed history of Campbell Newman Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 241,828 shares of ABT stock, worth $31.6 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

241,828

Previous 121,503 99.03%

Holding current value

$31.6 Million

Previous $13.7 Million 133.41%

% of portfolio

2.88%

Previous 1.17%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$111.1 - $140.22 $13.4 Million - $16.9 Million	120,325 Added 99.03%	241,828 $32.1 Million
Q4 2024 Jan 14, 2025	SELL	$111.93 - $119.39 $968,082 - $1.03 Million	-8,649 Reduced 6.65%	121,503 $13.7 Million
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $27,018 - $31,895	-270 Reduced 0.21%	130,152 $14.8 Million
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $310,852 - $346,989	-3,086 Reduced 2.31%	130,422 $13.6 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $135,585 - $149,748	-1,238 Reduced 0.92%	133,508 $15.2 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $187,865 - $229,963	-2,083 Reduced 1.52%	134,746 $14.8 Million
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $49,197 - $59,029	515 Added 0.38%	136,829 $13.3 Million
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $105,819 - $117,904	1,050 Added 0.78%	136,314 $14.9 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $60,731 - $71,484	-627 Reduced 0.46%	135,264 $13.7 Million
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $85,078 - $99,810	895 Added 0.66%	135,891 $0
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $86,987 - $100,714	-899 Reduced 0.66%	134,996 $13.1 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $985,281 - $1.19 Million	9,653 Added 7.65%	135,895 $14.8 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $54,273 - $66,183	-476 Reduced 0.38%	126,242 $14.9 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $39,049 - $47,813	338 Added 0.27%	126,718 $17.8 Million
Q3 2021 Oct 15, 2021	BUY	$116.66 - $129.06 $19,832 - $21,940	170 Added 0.13%	126,380 $14.9 Million
Q2 2021 Jul 16, 2021	SELL	$105.79 - $124.53 $52,577 - $61,891	-497 Reduced 0.39%	126,210 $14.6 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $11.2 Million - $13.2 Million	-102,811 Reduced 44.79%	126,707 $15.2 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $979,755 - $1.07 Million	9,331 Added 4.24%	229,518 $25.1 Million
Q3 2020 Oct 20, 2020	BUY	$91.64 - $111.29 $100,345 - $121,862	1,095 Added 0.5%	220,187 $24 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $296,019 - $378,868	3,866 Added 1.8%	219,092 $20 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $85,937 - $125,664	-1,368 Reduced 0.63%	215,226 $17 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $46,556 - $51,828	593 Added 0.27%	216,594 $18.8 Million
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $29,789 - $32,301	364 Added 0.17%	216,001 $18.1 Million
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $168,571 - $196,605	2,313 Added 1.08%	215,637 $18.1 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $134,161 - $162,201	-2,026 Reduced 0.94%	213,324 $17.1 Million
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $643,209 - $728,662	-9,811 Reduced 4.36%	215,350 $15.6 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $4.02 Million - $4.84 Million	66,036 Added 41.5%	225,161 $16.5 Million
Q2 2018 Jul 25, 2018	BUY	$57.57 - $63.54 $948,350 - $1.05 Million	16,473 Added 11.55%	159,125 $9.71 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $7.47 Million - $8.44 Million	132,723 Added 1336.72%	142,652 $8.55 Million
Q4 2017 Jan 25, 2018	BUY	$53.68 - $57.47 $2,469 - $2,643	46 Added 0.47%	9,929 $567,000
Q2 2017 Aug 09, 2017	BUY	N/A	9,883	9,883 $481,000

Others Institutions Holding ABT

# of Institutions

3,464

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.

Account

Campbell Newman Asset Management Inc Abbott Laboratories Transaction History